Home OSI Pharmaceuticals

OSI Pharmaceuticals

acquired
-
Targeted Therapy Drug Developer and Distributor
Basic
Enterprise Profile

Basic Information

OSI Pharmaceuticals is committed to developing and marketing high-quality targeted therapies to extend the lives of patients with cancer, diabetes, and obesity, and improve their quality of life.
OSI Pharmaceuticals, Inc.
NewYork,NewYork,United States of America
101~500 people
January 01, 1983
kgalante@osip.com

Enterprise Profile

Industrial Sector
New Drug Development Biological Drug Production
Technology
Targeted Technology
Concept
Tumor # Diabetes Mellitus Obesity
Application Scenarios
Innovative Drugs